Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Second-trimester Uterine Artery Doppler Analysis in the Prediction of GDM in a Low- Risk Population

NCT05488197 is registered in ClinicalTrials.gov with Haseki Training and Research Hospital as lead sponsor.

NCT NCT05488197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05488197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Second-trimester Uterine Artery Doppler Analysis in the Prediction of GDM in a Low- Risk Population
Lead sponsor
Haseki Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
June 10, 2021
Completion date
July 10, 2022
Enrollment
700 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes